Based on the above background, we speculated that a S1PR1–STAT3–IL-6–MDSCs signaling pathway may be involved in the promotion of growth and liver metastasis in CRC and that MDSCs could form a “premetastatic niche” for the CRC liver-specific metastasis. Here, IL6 is linked to colorectal carcinoma.